AVITA Medical (RCEL) Current Deferred Revenue (2022 - 2025)
AVITA Medical (RCEL) posted Current Deferred Revenue of $323000.0 for Q4 2025, down 2.42% on a QoQ basis from $331000.0 in Q3 2025, and down 9.52% year-over-year from $357000.0 in Q4 2024.
AVITA Medical (RCEL) Current Deferred Revenue (2022 - 2025) Analysis & Trends
AVITA Medical's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $323000.0 for Q4 2025.
- Quarterly Current Deferred Revenue fell 9.52% year-over-year to $323000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $323000.0 (down 9.52% YoY) and the FY2025 annual result came in at $323000.0, down 9.52% from the prior year.
- Current Deferred Revenue was $323000.0 for Q4 2025 at AVITA Medical, down from $331000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $698000.0 in Q4 2022 and bottomed at $205000.0 in Q2 2024.
- A 4-year average of $414000.0 and a median of $365000.0 in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue sank 63.2% — and 2025, when it soared 65.85%.
- AVITA Medical's Current Deferred Revenue stood at $698000.0 in 2022, then tumbled by 44.13% to $390000.0 in 2023, then fell by 8.46% to $357000.0 in 2024, then decreased by 9.52% to $323000.0 in 2025.
- Business Quant data shows RCEL's Current Deferred Revenue at $323000.0 in Q4 2025, $331000.0 in Q3 2025, and $340000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 323,000.00 |
| Sep 30, 2025 | 331,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Mar 31, 2025 | 348,000.00 |
| Dec 31, 2024 | 357,000.00 |
| Sep 30, 2024 | 365,000.00 |
| Jun 30, 2024 | 205,000.00 |
| Mar 31, 2024 | 382,000.00 |
| Dec 31, 2023 | 390,000.00 |
| Sep 30, 2023 | 469,000.00 |
| Jun 30, 2023 | 557,000.00 |
| Mar 31, 2023 | 617,000.00 |
| Dec 31, 2022 | 698,000.00 |